Photodynamic Therapy for Atherosclerosis: Past, Present, and Future

Area of Science:

• Cardiovascular Research
• Medical Technology
• Oncology (Therapeutic Applications)

Background:

• Atherosclerosis, a leading cause of cardiovascular disease, involves arterial lipid accumulation and inflammation.
• Current treatments focus on risk factors, but inflammation's role is increasingly recognized.
• Minimally invasive strategies are needed to address the high morbidity and mortality associated with atherosclerosis.

Purpose of the Study:

• To review the evolution and potential of photodynamic therapy (PDT) for treating atherosclerosis.
• To explore PDT's mechanistic basis, preclinical efficacy, and application in plaque stabilization.
• To identify future research needs for clinical translation of PDT in cardiovascular medicine.

Main Methods:

• Review of existing literature on photodynamic therapy (PDT) and atherosclerosis.
• Analysis of PDT's mechanism involving photosensitizers, light, and oxygen.
• Examination of preclinical data on PDT's effects on atherosclerotic plaques and macrophage infiltration.

Main Results:

• PDT demonstrates targeted cell death in diseased arterial tissue, sparing healthy cells.
• Nanoparticle advancements enhance PDT delivery and therapeutic potential.
• Preclinical studies suggest PDT can improve plaque stability and reduce macrophage density.

Conclusions:

• Photodynamic therapy (PDT) presents a promising, targeted approach for atherosclerosis treatment.
• Further research is required to optimize PDT parameters, manage side effects, and confirm long-term clinical outcomes.
• PDT has the potential to significantly advance atherosclerosis management from research to clinical practice.